Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Hairui Pharmaceutical is a major subsidiary and the South China production and R&D base of the Yangtze River Pharmaceutical Group. Established in 2004 and located in the Guangzhou Science City, the company specializes in the development and large-scale manufacturing of high-quality pharmaceutical preparations. Its product portfolio primarily focuses on therapeutic areas such as anti-infectives, digestive system disorders, cardiovascular diseases, and respiratory health. The company operates advanced, GMP-certified production lines for multiple dosage forms, including tablets, capsules, and granules. As a key component of one of China's largest pharmaceutical conglomerates, Guangzhou Hairui plays a vital role in the group's regional expansion and supply chain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Hairui Pharmaceutical.